BACKGROUND: The feasibility of robot-assisted gastrectomy (RG) in terms of safety is unclear due to a lack of prospective studies. We showed feasible surgical outcomes in our previous study. In this phase II study, we assessed feasibility of the procedure by recruiting a larger number of @entity1 . METHOD: This single-center, prospective phase II study included @entity1 with clinical stage I @entity356 undergoing RG. The primary end point was the incidence of @entity260 , including @entity834 , @entity281 , and @entity6177 . The secondary end points were overall survival, relapse-free survival, RG completion rate, and incidence of all surgical morbidities. RESULTS: A total of 120 @entity1 were recruited between December 2012 and April 2015. The incidence of intra-abdominal infectious complications was 3.3  % (95  % CI 0.9-8.3  %), and all complications were successfully treated conservatively without re-operation. The incidence of overall adverse events was 14.2  % (95  % CI 8.5-21.7  %). Three @entity1 required conversion to open gastrectomy according to the protocol due to @entity1442 . CONCLUSION: Our data show that RG is safe in terms of the incidence and severity of @entity260 .

Late phase II study of robot-assisted gastrectomy with nodal dissection for clinical stage I XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity834 :: ('MESH:D057868', 'Disease') :: ['anastomotic leakage'] @entity6177 :: ('MESH:D018784', 'Disease') :: ['intra-abdominal abscess'] @entity260 :: ('MESH:D011183', 'Disease') :: ['postoperative intra-abdominal infectious complications', 'postoperative complications'] @entity281 :: ('MESH:D007239', 'Disease') :: ['pancreas-related infection'] @entity1442 :: ('MESH:D020178', 'Disease') :: ['advancement of disease'] @entity356 :: ('MESH:D013274', 'Disease') :: ['gastric cancer']
@entity356 :: (MESH:D013274,Disease) :: ['gastric cancer']
